Dr. Reddy’s Laboratories Recalls Prescription Drug Blister Packages Due to Potential Health Risk

Dr. Reddy’s Laboratories of Princeton, N.J., recalled over 21,400 blister packages due to inappropriate packaging.

The products are prescription medications that were labeled and distributed by Dr. Reddy’s for institutional use only.

The prescription medications were distributed by third party wholesalers to retail pharmacies and could have been dispensed to consumers.

The packaging of the products is not child resistant and can pose a risk of poisoning if the contents are swallowed by young children.

This recall involves blister packages of the following prescription medications:

  • Imatinib Mesylate Tablets 100 mg
  • Imatinib Mesylate Tablets 400 mg
  • Pregabalin Capsules 50 mg
  • Pregabalin Capsules 75 mg
  • Pregabalin Capsules 100 mg
  • Pregabalin Capsules 150 mg
  • Sevelamer Carbonate Tablets 800 mg
  • Tadalafil Tablets 5 mg 
  • Tadalafil Tablets 20 mg.

The recalled products were manufactured in India and were sold to wholesalers by Dr. Reddy’s.

Dr. Reddy’s Laboratories urges consumers to immediately store the recalled medications in a safe location out of reach of children and contact Dr. Reddy’s for a full refund.

There have been incidents or injuries have been reported to date.


© Fourth Estate® — All Rights Reserved.
This material may not be published, broadcast, rewritten or redistributed.